NCT03450720View on ClinicalTrials.gov

Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

August 16, 2017

Study Completion Date

August 16, 2017

Conditions

Cystic Fibrosis

Interventions

DRUG

GLPG2737 single dose

GLPG2737 oral suspension, single dose

Trial Locations (1)

Unknown

UZ KU Leuven, Leuven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY